Last kr127.50 SEK
Change Today +8.50 / 7.14%
Volume 115.8K
ORX On Other Exchanges
Symbol
Exchange
Stockholm
Berlin
OTC US
OTC US
As of 11:30 AM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Raymond G. Hill B. Pharm., Ph.D., D.Sc., (Hon) F. Med. Sci

Director and Member of Remuneration Committee, Orexo AB
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 5 different industries.

See Board Relationships
69--

Background*

Dr. Raymond G. Hill, B. Pharm., Ph.D., D.Sc., (Hon) F. Med. Sci, is an Advisor of Inflection Biosciences Ltd. Dr. Hill served as Executive Director of Licensing & External Research - Europe of Merck Sharp & Dohme Research Laboratories, a subsidiary of Merck & Co., Inc. from 2002 to April 30, 2008. From 1997 to 2002, Dr. Hill served as Executive Director of Pharmacology at Neuroscience Research Centre engaged in drug discovery for Neuroscience indications at Merck. He ...

Read Full Background

Corporate Headquarters*

Virdings allé 32 A
Uppsala, Uppsala County 751 05

Sweden

Phone: 46 1 87 80 88 00
Fax: 46 1 87 80 88 88

Board Members Memberships*

Director
2008-2013
Former Director, Chairman of Compensation Committee and Member of Nomination Committee
2008-Present
Director and Member of Remuneration Committee
2011-N/A
Former Board Member

Education*

PhD
University Of London
Bachelor's Degree
University Of London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORX:SS kr127.50 SEK +8.50

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXO AB, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.